BioSpace News Archive

Retrophin, Inc. announced that Company management will present at the following upcoming investor conferences in February and March

Conformis, Inc. announced that the Orthopaedic Data Evaluation Panel in the United Kingdom awarded the Conformis iTotal® CR knee replacement system a “5A” rating.

As another example of Ohio’s commitment to attracting top talent and public-private partnerships, three cities: Gahanna, Mason, and Mentor, in partnership with BioOhio, Ohio’s bioscience trade association, announced each city will host a Regional Bioscience Career Fair during the week of February 24th, 2020.

RedHawk Holdings Corp. announced financial results for the three and six month periods of fiscal 2020, ended December 31, 2019.

Aeterna Zentaris Inc. announced that it has entered into a securities purchase agreement with several institutional investors in the United States providing for the sale and issuance of approximately 3,478,261 common shares at a purchase price of $1.29375 per common share in a registered direct offering priced at-the-market under Nasdaq rules.

Transaction to Create Nasdaq-listed Company Focused on Advancing Forte’s Late-Stage Clinical Program for Atopic Dermatitis

The general public has come to see the taking of social responsibility as a basic requirement of all companies.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, today announced plans to participate in the upcoming Cowen Health Care Conference in Boston, Massachusetts.

Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019.

Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior management to discuss the company’s fourth quarter and full year 2019 financial results and provide an operational update on Tuesday, Feb. 25, 2020, at 4:30 p.m. ET.